Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Avita Medical, Inc. - Common Stock (NQ:RCEL)

10.70 -0.32 (-2.90%)
Streaming Delayed Price Updated: 1:20 PM EDT, Sep 21, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Avita Medical, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >
News headline image
Avita Medical PermeaDerm Study Shows 70% Cost Reduction vs. Allograft ↗
Avita Medical (NASDAQ:RCEL) presented results from its PermeaDerm-I study, a randomized controlled trial evaluating PermeaDerm as temporary wound coverage following excision and before split-thickness... 
Via MarketBeat
News headline image
Avita Medical Raises 2026 Revenue Outlook as Q2 Sales Climb 18% ↗
Avita Medical (NASDAQ:RCEL) reported second-quarter 2026 revenue of $21.7 million, up 13% sequentially from $19.3 million in the first quarter and 18% from $18.4 million a year earlier, as the... 
Via MarketBeat
News headline image
Avita Medical Targets Q4 2025 Cash Flow Breakeven as Revenue Growth Builds ↗
Avita Medical (NASDAQ:RCEL) expects continued sequential revenue growth and aims to reach cash flow breakeven in the fourth quarter of 2025, President and CEO Cary Vance said at the Canaccord 46th... 
Via MarketBeat
News headline image
AVITA Medical (RCEL) Q2 2026 Earnings Call Transcript ↗
Revenue exceeded $21.7 million with guidance raised to $86M–$89M for full year. 
Via The Motley Fool
Topics Earnings
Avita Medical (NASDAQ:RCEL) Beats Q2 Estimates and Raises Full-Year Guidance ↗
Via Chartmill
AVITA Medical (NASDAQ:RCEL) Q1 2026 Revenue Beat Fails to Offset Wider Loss, Stock Still Rises on Outlook ↗
Via Chartmill
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
Gainers AVITA Medical (NASDAQ:RCEL) stock rose 58.4% to $7.53 during Friday's regular session. The company's market cap stands at $146.1 million. As per the press release, Q2 earnings came out... 
Via Benzinga
What's going on in today's session ↗
Via Chartmill
Which stocks are gapping on Friday? ↗
Via Chartmill
News headline image
Avita Medical Q2 Earnings Call Highlights ↗
Avita Medical (NASDAQ:RCEL) reported second-quarter 2026 revenue of $21.7 million, up 18% from a year earlier and 13% sequentially, as growth in its RECELL wound-care product and newer portfolio... 
Via MarketBeat
Topics Earnings
AVITA Medical Inc (NASDAQ:RCEL) Reports Mixed Q4 2025 Results, Provides 2026 Guidance ↗
Via Chartmill
News headline image
Earnings Scheduled For November 6, 2025 ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
Gainers AVITA Medical (NASDAQ:RCEL) stock moved upwards by 11.1% to $4.9 during Thursday's after-market session. The market value of their outstanding shares is at $143.1 million. Lisata Therapeutics... 
Via Benzinga
News headline image
Avita (RCEL) Q1 2026 Earnings Call Transcript ↗
Avita (RCEL) Q1 2026 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
Let's uncover which stocks are experiencing notable gaps during today's session. ↗
Via Chartmill
News headline image
Avita Medical Q1 Earnings Call Highlights ↗
Avita Medical (NASDAQ:RCEL) reported first-quarter 2026 revenue growth and reaffirmed its full-year outlook as management said reimbursement conditions for its RECELL product are normalizing and demand... 
Via MarketBeat
Topics Earnings
News headline image
AVITA Medical (RCEL) Q4 2025 Earnings Transcript ↗
AVITA Medical (RCEL) Q4 2025 Earnings Transcript 
Via The Motley Fool
News headline image
This Nasdaq Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday ↗
 
Via Benzinga
News headline image
AVITA Medical (NASDAQ:RCEL) Reports Mixed Q3 2025 Results, Cuts Revenue Outlook Amid Reimbursement Headwinds ↗
AVITA Medical's Q3 revenue missed estimates due to reimbursement headwinds, but the company improved cost control and secured key Medicare pricing. 
Via Chartmill
News headline image
AVITA Medical (RCEL) Q3 2025 Earnings Transcript ↗
AVITA Medical (RCEL) Q3 2025 Earnings Transcript 
Via The Motley Fool
News headline image
Top movers in Friday's session ↗
Keep an eye on the top gainers and losers in Friday's session, as they reflect the most notable price movements. 
Via Chartmill
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
 
Via Benzinga
News headline image
Top stock movements in today's session. ↗
Looking for insights into the US markets in the middle of the day on Friday? Delve into the top gainers and losers of today's session and gain valuable market intelligence. 
Via Chartmill
News headline image
This Booz Allen Hamilton Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday ↗
 
Via Benzinga
News headline image
Which stocks are gapping on Friday? ↗
Traders are paying attention to the gapping stocks in Friday's session. Let's dive into which stocks are experiencing notable gaps. 
Via Chartmill
News headline image
Discover the top movers in Friday's pre-market session. ↗
Before the US market kicks off on Friday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers. 
Via Chartmill
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Here are the top movers in Monday's session. ↗
Curious about what's happening in today's session? Check out the latest stock movements and price changes. 
Via Chartmill
News headline image
12 Health Care Stocks Moving In Monday's Intraday Session ↗
 
Via Benzinga
News headline image
Which stocks are moving on Monday? ↗
Looking for insights into the US markets in the middle of the day on Monday? Delve into the top gainers and losers of today's session and gain valuable market intelligence. 
Via Chartmill
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.